Synopsis:Management of this company projected around 70 percent revenue growth in FY27 and raised its full-year revenue guidance, bringing this stock into the spotlight. The shares of this company, which is an Indian manufacturer and global exporter of male condoms,...
Synopsis: Tata Motors Passenger Vehicles, Netweb Technologies, Waaree Energies, KPI Green Energy, and Jeena Sikho Lifecare have outlined strong growth targets through FY31, backed by expansion and revenue projections. India’s economy is expected to witness...
Synopsis: Top Indian real estate developers are projected to deliver strong FY27 pre-sales growth led by Godrej, Prestige, and Lodha, with most firms expanding 14–37% on robust launches, demand strength, and geographic diversification across key urban markets. India’s...
Synopsis: Pace Digitek updated multiple strategic initiatives, including manufacturing expansion, research investments, subsidiary restructuring, and, aimed at strengthening its position in the rapidly growing energy storage sector. The shares of this small cap...
Synopsis: The share of this company surged after Nykaa outlined a FY30 vision targeting revenue growth to Rs 43,000 crore, driven by strong Beauty, Fashion, and B2B expansion plans. The share of this company, which is a leading Indian omnichannel e-commerce retailer...
Synopsis: This company is scaling its US business through product launches, regulatory approvals, and a strong pipeline, aiming to reach USD 1 billion in revenue driven by respiratory and specialty segment expansion. The article outlines the target and capacity of the...
Synopsis: This small-cap infrastructure company has guided for FY27 revenue of Rs.3,200–3,400 crore, implying growth of up to 29 percent, backed by an executable order book of Rs.11,338 crore. The company is also expanding its BESS manufacturing capacity from 2.5 GWh...
Synopsis A leading global agrochem company slashes debt by $850 Mn, earns rating upgrades from three global agencies, and nearly quadruples its profit in a single year – all while beating every guidance metric it set. In a year marked by falling commodity...
Synopsis: Shares of this company rose about 4 percent after strong FY30 growth guidance, including 100 percent revenue growth target, higher market share plans, and robust Q4 performance across key business segments The share of this company, which is India’s leading...
Synopsis: The share of this pharmaceutical company came into focus after reporting Q4 FY26 results and outlining a plan to achieve nearly 50 percent revenue growth over the next three years. The shares of this company, which is focused heavily on R&D and novel...
